Adamis Pharmaceuticals Corp. (ADMP) Starts Presentation at LD Micro Conference

Adamis Pharmaceuticals Corp. is an emerging pharmaceutical company focused on combining specialty pharmaceuticals and biotechnology to provide innovative medicines for patients and physicians. Primarily focused on its specialty pharmaceutical products, Adamis is currently developing four products in the allergy and respiratory markets to create low-cost therapeutic alternatives to existing treatments. The company also has several biotech product candidates and technologies, including therapeutic vaccine and cancer product candidates and technologies for patients in the global cancer market. For more information, visit the company’s website at www.adamispharmaceuticals.com.